0 0

Vivo Capital (VCT)

At Vivo Capital, we leverage our internal expertise in evaluating data to generate outsized returns for company founders and employees as well as for our investors. Vivo invests primarily in later development stage pharmaceutical and medical device companies in the U.S. and in revenue stage healthcare companies in greater China. Vivo assists its portfolio companies in both countries in forging cross-border partnerships, enabling the companies to acquire new products and expand the market for their existing products. In addition to making investments in existing companies, Vivo also builds companies from scratch to pursue compelling opportunities together with experienced management teams. Finally, a portion of every Vivo fund is invested directly into public therapeutics companies. Despite its focus on companies with later-stage products, Vivo is willing to work with companies (and their founders) that may not have significant infrastructure. We invest in companies with promising products at all financing stages (Series A to public companies), and work closely with founders and management to complete the development and commercial launch of those products and achieve a successful exit.

Type Token
Website Open
Total Supply 88,000,000,000
Whitepaper View
Bitcoin Talk Open
Token Sale Start Date October 1, 2018
Token Sale End Date December 31, 2018
Video
Latest Tweets

ICO (Initial Coin Offerings) / STO (Security Token Offerings)

List your ICO, STO or Tokens over ICOsComing.com before investing in any ICO, STO or Tokens its best to do your own research and analysis before making any investment. ICOsComing.com content is intended to be used and must be used for informational purposes only. Please review Disclaimer & Privacy Policy.

Leave a Reply

Your email address will not be published. Required fields are marked *